scholarly article | Q13442814 |
P2093 | author name string | Forrester JV | |
Dick AD | |||
Kilmartin DJ | |||
P2860 | cites work | Systemic Uveitis Syndromes in Childhood: An Analysis of 340 Cases | Q70230626 |
Dosage of Cyclosporin A in children with renal transplants | Q70380738 | ||
Management of pituitary-adrenal suppression secondary to corticosteroid therapy | Q70806532 | ||
Behçets disease in children | Q70939834 | ||
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis | Q70998593 | ||
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents | Q71020371 | ||
FK506 treatment of noninfectious uveitis | Q71659308 | ||
Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantation | Q71695601 | ||
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease | Q72042895 | ||
Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation | Q72098102 | ||
The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study | Q72314582 | ||
Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipients | Q72326289 | ||
Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring | Q72343561 | ||
Growth after renal transplantation in prepubertal children: impact of various treatment modalities | Q72438510 | ||
Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood | Q72771725 | ||
Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection | Q73138186 | ||
Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease | Q73211674 | ||
Endogenous uveitis in children; associated band-shaped keratopathy and rheumatoid arthritis | Q73280674 | ||
Uveitis in children | Q73318773 | ||
Neoral--new cyclosporin for old? | Q73891154 | ||
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis | Q93559746 | ||
UVEITIS IN CHILDREN: ANALYSIS OF 274 CASES | Q34204652 | ||
Paediatric cardiac transplantation with steroid-sparing maintenance immunosuppression | Q35628600 | ||
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II | Q36061342 | ||
Pattern of uveitis in children | Q37335634 | ||
Immunosuppressive drugs in immune and inflammatory ocular disease | Q37729973 | ||
Juvenile arthritis and uveitis | Q37924969 | ||
Uveitis in childhood--Part I. Anterior. | Q38613222 | ||
Uveitis in childhood--Part II. Intermediate | Q38613224 | ||
Uveitis in childhood--Part III. Posterior | Q38613226 | ||
Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation | Q40380386 | ||
Renal transplantation in young children | Q40441281 | ||
Changing patterns in uveitis of childhood | Q40949447 | ||
Safety aspects of cyclosporin in rheumatoid arthritis. | Q41038080 | ||
International consensus recommendations on cyclosporin use in rheumatoid arthritis | Q41038087 | ||
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A | Q41719098 | ||
Low dose cyclosporin A therapy in chronic posterior uveitis | Q44276629 | ||
Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation | Q44621307 | ||
Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood | Q45009477 | ||
Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease. | Q51032239 | ||
Pediatric intermediate uveitis. | Q52533677 | ||
Plasma creatinine and urea concentration in children: Normal values for age and sex | Q67452772 | ||
Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children | Q67757027 | ||
Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis | Q67938095 | ||
Long-term results of cyclosporin A therapy in children | Q68009683 | ||
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases | Q68129476 | ||
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease | Q69741243 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | uveitis | Q280027 |
cyclosporine | Q367700 | ||
P304 | page(s) | 737-742 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | British Journal of Ophthalmology | Q13443571 |
P1476 | title | Cyclosporin A therapy in refractory non-infectious childhood uveitis | |
P478 | volume | 82 |
Q37479820 | A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). |
Q41994612 | An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis |
Q36025876 | Biological response modifier therapy for refractory childhood uveitis |
Q42714905 | Challenges of childhood uveitis |
Q35580562 | Clinical trials in pediatric uveitis |
Q44517198 | Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells |
Q27693189 | Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation |
Q44743074 | Etanercept therapy in children with treatment-resistant uveitis |
Q37956187 | Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis |
Q35711324 | Experience with cyclosporine in endogenous uveitis posterior |
Q34070773 | High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis |
Q36371451 | Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature |
Q35760145 | Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis |
Q35825121 | Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up |
Q26749339 | Juvenile idiopathic arthritis-associated uveitis |
Q46542282 | Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis |
Q34574284 | Management of uveitis in pediatric patients: special considerations |
Q36584169 | Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry |
Q37535944 | Non-infectious pediatric uveitis: an update on immunomodulatory management |
Q36676241 | Ocular complications of childhood rheumatic diseases: uveitis |
Q38119243 | Overview and recent developments in the medical management of paediatric uveitis |
Q35113997 | Pediatric uveitis |
Q38123032 | Pediatric uveitis: new and future treatments |
Q34374469 | Prognostic factors in juvenile idiopathic arthritis |
Q34789195 | Response of pediatric uveitis to tumor necrosis factor-α inhibitors |
Q35145997 | Special considerations in the evaluation and management of uveitis in children |
Q35902397 | Treatment of ocular inflammation in children |
Q34965097 | Treatment of rheumatic diseases in children: special considerations. |
Q58326249 | Treatment strategies for childhood noninfectious chronic uveitis: an update |
Q36388536 | Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. |
Q35582804 | Use of immunosuppressive agents in uveitis |
Q38396962 | Uveitis associated with juvenile idiopathic arthritis |
Q86322030 | Uveitis in Children: Diagnosis and Management |
Q35591193 | Visual loss in uveitis of childhood |
Q86108091 | [Therapy of intermediate uveitis] |